Be Bio Announces Appointment of Cell and Gene Therapy Veterans Joanne Smith-Farrell, Ph.D., as Chief Executive Officer and Rick Morgan, Ph.D., as Chief Scientific Officer March 18, 2021
Pulmocide announces publication of clinical data in two peer-reviewed publications highlighting potential of PC945, a novel inhaled antifungal drug candidate, in lung infections March 11, 2021
ImmuneID Launches with $17M Financing to Profile and Modulate Immune Response at Unprecedented Scale and Resolution February 18, 2021
Stephen Elledge’s Harvard lab takes $17M to birth ImmuneID, a high-throughput antibody startup February 18, 2021
Immunitas Therapeutics Announces Cell Publication of Tumor Single Cell Analysis Identifying CD161 as a Therapeutic T and NK Cell Target in Immuno-Oncology February 18, 2021
Results from Axial Therapeutics Phase1b/2a Study of AB-2004 in Adolescents with Autism Spectrum Disorder Met Primary Endpoint and Reduced Irritability and Other Symptoms December 7, 2020
